Suppr超能文献

[氯硝西泮的中枢作用]

[Central effects of clonazepam].

作者信息

Ono N, Furukawa T

出版信息

Nihon Yakurigaku Zasshi. 1976 Apr;72(3):297-312. doi: 10.1254/fpj.72.297.

Abstract

The effects of oral administration of clonazepam, a new benzodiazepine derivative (F. Hoffmann-La Roche), on the central nervous system were compared with those of diazepam and several anticonvulsants in mice and rats. 1) Clonazepam exhibited a moderate inhibitory effect on the locomotor activity observed with open-field situation in mice and no effect in rats, while it inhibited markedly the rearing behavior in both animals, the duration of action being approximately six hours. 2) Clonazepam potentiated the methamphetamine-induced hyper-locomotor activity in mice whereas trimethadione had no effect. 3) Clonazepam inhibited with a moderate potency the conditioned avoidance response and response to a fixed-ratio (FR 20) schedule of food reinforcement in rats, the potency being a little weaker than that of diazepam. 4) The muscle relaxant effect of clonazepam determined by the traction test was slightly more potent as compared with that of diazepam. Thiopental hypnosis was markedly potentiated after clonazepam. 5) The clonic (CL), tonic-flexor (TF) and extensor convulsions (TE) induced by pentetrazol were strongly inhibited after clonazepam in mice, anticonvulsant potency against CL and TE of clonazepam being approximately 23 and 21 times stronger than that of diazepam, 3333 and 3846 times that of trimethadione, and over 3047 and 178 times that of phenytoin, respectively. Clonazepam reduced markedly CL and TE elicited by bemegride with about 12 to 14 times stronger potency than diazepam. On the contrary, the anticonvulsant effect of clonazepam against TE of maximal electroshock seizure evoked by supramaximal current was weak, the potency being 0.71 times weaker than that of phenacemide, 0.14 times than phenytoin and 0.24 times than phenobarbital. By the combined administration of clonazepam with other anticonvulsants such as trimethadione and phenytoin against pentetrazol convulsion, and phenacemide, phenytoin and phenobarbital against maximal electroshock seizure, the antagonistic effect of these anticonvulsants was potentiated by 4 to 5 times. 6) The acute toxicity (LD50) of clonazepam was weak but that of phenacemide or phenytoin was potentiated to a certain degree by combined administration with clonazepam. The results suggest that clonazepam has a psychopharmacological profile similar to that of benzodiazepines with a particularly potent anticonvulsant effect on pentetrazol and bemegride convulsions, and the anticonvulsant effect is synergic with that of other anticonvulsants.

摘要

将新型苯二氮䓬衍生物氯硝西泮(F. 霍夫曼 - 罗氏公司生产)口服给药对中枢神经系统的影响,与地西泮及几种抗惊厥药在小鼠和大鼠身上的影响进行了比较。1)氯硝西泮对小鼠旷场实验中观察到的自发活动有中等程度的抑制作用,对大鼠则无影响,同时它能显著抑制两种动物的竖毛行为,作用持续时间约为6小时。2)氯硝西泮能增强甲基苯丙胺诱导的小鼠活动亢进,而三甲双酮则无此作用。3)氯硝西泮对大鼠的条件性回避反应及固定比率(FR 20)食物强化反应有中等强度的抑制作用,效力略弱于地西泮。4)通过牵引试验测定,氯硝西泮的肌肉松弛作用比地西泮稍强。氯硝西泮给药后硫喷妥钠催眠作用明显增强。5)氯硝西泮能强烈抑制小鼠戊四氮诱发的阵挛性(CL)、强直性 - 屈肌性(TF)和伸肌性惊厥(TE),氯硝西泮对CL和TE的抗惊厥效力分别比地西泮强约23倍和21倍,比三甲双酮强3333倍和3846倍,比苯妥英强3047倍和178倍以上。氯硝西泮能显著降低贝美格诱发的CL和TE,效力比地西泮强约12至14倍。相反,氯硝西泮对超强电流诱发的最大电休克惊厥的TE的抗惊厥作用较弱,效力比苯乙酰胺弱0.71倍,比苯妥英弱0.14倍,比苯巴比妥弱0.24倍。氯硝西泮与其他抗惊厥药如三甲双酮和苯妥英联合用于对抗戊四氮惊厥,以及与苯乙酰胺、苯妥英和苯巴比妥联合用于对抗最大电休克惊厥时,这些抗惊厥药的拮抗作用增强了4至5倍。6)氯硝西泮的急性毒性(LD50)较弱,但苯乙酰胺或苯妥英与氯硝西泮联合给药时其毒性有一定程度的增强。结果表明,氯硝西泮具有与苯二氮䓬类药物相似的精神药理学特征,对戊四氮和贝美格惊厥有特别强的抗惊厥作用,且其抗惊厥作用与其他抗惊厥药具有协同作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验